BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saelaert M, Mertes H, De Baere E, Devisch I. Incidental or secondary findings: an integrative and patient-inclusive approach to the current debate. Eur J Hum Genet 2018;26:1424-31. [PMID: 29970927 DOI: 10.1038/s41431-018-0200-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Poole OV, Pizzamiglio C, Murphy D, Falabella M, Macken WL, Bugiardini E, Woodward CE, Labrum R, Efthymiou S, Salpietro V, Chelban V, Kaiyrzhanov R, Maroofian R, Amato AA, Gregory A, Hayflick SJ, Jonvik H, Wood N, Houlden H, Vandrovcova J, Hanna MG, Pittman A, Pitceathly RDS; SYNaPS Study Group., Queen Square Genomics. Mitochondrial DNA Analysis from Exome Sequencing Data Improves Diagnostic Yield in Neurological Diseases. Ann Neurol 2021;89:1240-7. [PMID: 33704825 DOI: 10.1002/ana.26063] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Basel-Salmon L, Sukenik-Halevy R. Challenges in variant interpretation in prenatal exome sequencing. Eur J Med Genet 2021;65:104410. [PMID: 34952236 DOI: 10.1016/j.ejmg.2021.104410] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Rost C, Dent KM, Botkin J, Rothwell E. Experiences and lessons learned by genetic counselors in returning secondary genetic findings to patients. J Genet Couns 2020;29:1234-44. [PMID: 32453499 DOI: 10.1002/jgc4.1292] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
4 Matsui K, Yamamoto K, Tashiro S, Ibuki T. A systematic approach to the disclosure of genomic findings in clinical practice and research: a proposed framework with colored matrix and decision-making pathways. BMC Med Ethics 2021;22:168. [PMID: 34953504 DOI: 10.1186/s12910-021-00738-9] [Reference Citation Analysis]
5 Liu Z, Zhu L, Roberts R, Tong W. Toward Clinical Implementation of Next-Generation Sequencing-Based Genetic Testing in Rare Diseases: Where Are We? Trends Genet 2019;35:852-67. [PMID: 31623871 DOI: 10.1016/j.tig.2019.08.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
6 Saelaert M, Mertes H, Moerenhout T, De Baere E, Devisch I. Criteria for reporting incidental findings in clinical exome sequencing - a focus group study on professional practices and perspectives in Belgian genetic centres. BMC Med Genomics 2019;12:123. [PMID: 31429751 DOI: 10.1186/s12920-019-0561-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
7 Zakeri M, Safaiee MS, Taheri F, Taghizadeh E, Ferns GA, Mobarhan MG, Pasdar A. Secondary findings from whole-exome sequencing data in families with familial combined hyperlipidemia (FCHL). Egypt J Med Hum Genet 2021;22. [DOI: 10.1186/s43042-021-00195-4] [Reference Citation Analysis]
8 Mann SP, Treit PV, Geyer PE, Omenn GS, Mann M. Ethical Principles, Constraints and Opportunities in Clinical Proteomics. Mol Cell Proteomics 2021;:100046. [PMID: 33453411 DOI: 10.1016/j.mcpro.2021.100046] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
9 Eichinger J, Elger BS, Koné I, Filges I, Shaw D, Zimmermann B, McLennan S. The full spectrum of ethical issues in pediatric genome-wide sequencing: a systematic qualitative review. BMC Pediatr 2021;21:387. [PMID: 34488686 DOI: 10.1186/s12887-021-02830-w] [Reference Citation Analysis]
10 Rosier M, Guedj M, Calvas P, Julia S, Garnier C, Cambon-Thomsen A, Muñoz Sastre MT. Attitudes of French populations towards the disclosure of unsolicited findings in medical genetics. J Health Psychol 2021;26:1767-79. [PMID: 31707852 DOI: 10.1177/1359105319886622] [Reference Citation Analysis]
11 McInerney-Leo AM, Duncan EL. Massively Parallel Sequencing for Rare Genetic Disorders: Potential and Pitfalls. Front Endocrinol (Lausanne) 2020;11:628946. [PMID: 33679611 DOI: 10.3389/fendo.2020.628946] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Hercher L. Discouraging Elective Genetic Testing of Minors: A Norm under Siege in a New Era of Genomic Medicine. Cold Spring Harb Perspect Med 2020;10:a036657. [PMID: 31548217 DOI: 10.1101/cshperspect.a036657] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
13 Wagener R, Walter C, Surowy HM, Brandes D, Soura S, Alzoubi D, Yasin L, Fischer U, Dugas M, Borkhardt A, Brozou T. Noncancer-related Secondary Findings in a Cohort of 231 Children With Cancer and Their Parents. J Pediatr Hematol Oncol 2022. [PMID: 35537032 DOI: 10.1097/MPH.0000000000002475] [Reference Citation Analysis]
14 Fontes Marx M, Ataguba JE, de Vries J, Wonkam A. Systematic Review of the Economic Evaluation of Returning Incidental Findings in Genomic Research. Front Public Health 2021;9:697381. [PMID: 34277554 DOI: 10.3389/fpubh.2021.697381] [Reference Citation Analysis]
15 Antonova N, Eritsyan K. It is not a big deal: a qualitative study of clinical biobank donation experience and motives. BMC Med Ethics 2022;23. [DOI: 10.1186/s12910-022-00743-6] [Reference Citation Analysis]
16 Hochstenbach R, van Binsbergen E, Schuring-Blom H, Buijs A, Ploos van Amstel HK. A survey of undetected, clinically relevant chromosome abnormalities when replacing postnatal karyotyping by Whole Genome Sequencing. Eur J Med Genet 2019;62:103543. [PMID: 30248410 DOI: 10.1016/j.ejmg.2018.09.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]